Mesoblast leads the pack with 8.7% share price gain
MELBOURNE: Stem cell treatments maker Mesoblast finished today’s session up 8.7 per cent to $1.93
MELBOURNE: Stem cell treatments maker Mesoblast finished today’s session up 8.7 per cent to $1.93
FEATURED
Construction loan now secured for innovative seniors community
Senior living operators plan more moderate rental rate growth
10-storey apartments under 1500-home plan around golf course
High rise living above casino pitched to boomer market
Pilot study to improve staff interactions with residents with dementia
Senior living marketing leaps into digital age with innovations
INNOVATION
